18.03.2014 • News

Merck Serono Names Meeta Gulyani to Pharma Executive Committee

Merck Serono, the biopharmaceutical division of Germany's Merck KGaA, has named Meeta Gulyani as head of strategy and global franchises, effective May 7. She will be based in Boston, Massachusetts, U.S. and report to Merck Serono CEO Belén Garijo.

Ms Gulyani will lead Merck Serono's global franchises of multiple sclerosis & immunology, oncology, fertility, general medicine & endocrinology and medical devices, with a strong focus on defining integrated strategies for disease areas.

With this appointment, and the promotion of Elcin Ergun on Jan, 1 as head of commercial, Merck Serono's Pharmaceutical Executive Committee is now complete.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

From Lab to Market Challenge

Vote Now: Germany's Most Promising Chemistry Start-ups
Choose your favourite among the finalists

Vote Now: Germany's Most Promising Chemistry Start-ups

The "From Lab to Market Challenge" brings together the most promising founders from chemistry, materials science, and industrial biotechnology. Starting June 1st, you can cast your public vote for the finalists on CHEManager.com — before the award ceremony with €10,000 in prizes takes place on June 25th.

Top-Feature

most read

Photo
News • Chemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.